{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T19:18:26Z","timestamp":1788722306442,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ajem.2024.03.005","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T03:06:17Z","timestamp":1710299177000},"page":"35-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Efficacy and safety of tranexamic acid in acute traumatic brain injury: A meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"80","author":[{"given":"Minzhi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0506-3356","authenticated-orcid":false,"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ajem.2024.03.005_bb0005","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1474-4422(17)30371-X","article-title":"Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research","volume":"16","author":"Maas","year":"2017","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.ajem.2024.03.005_bb0010","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S1474-4422(22)00309-X","article-title":"Traumatic brain injury: progress and challenges in prevention, clinical care, and research","volume":"21","author":"Maas","year":"2022","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.ajem.2024.03.005_bb0015","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1089\/neu.2007.0385","article-title":"Progression of traumatic intracerebral hemorrhage: a prospective observational study","volume":"25","author":"Narayan","year":"2008","journal-title":"J Neurotrauma"},{"issue":"5","key":"10.1016\/j.ajem.2024.03.005_bb0020","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3171\/jns.1980.52.5.0611","article-title":"Neurological course and correlated computerized tomography findings after severe closed head injury","volume":"52","author":"Clifton","year":"1980","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.ajem.2024.03.005_bb0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/TA.0000000000002706","article-title":"Blood-based biomarkers for prediction of intracranial hemorrhage and outcome in patients with moderate or severe traumatic brain injury","volume":"89","author":"Anderson","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"issue":"5","key":"10.1016\/j.ajem.2024.03.005_bb0030","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2165\/11209070-000000000-00000","article-title":"Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis","volume":"72","author":"McCormack","year":"2012","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.ajem.2024.03.005_bb0035","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1186\/s13054-020-03243-4","article-title":"Understanding the neuroprotective effect of tranexamic acid: An exploratory analysis of the CRASH-3 randomised trial","volume":"vol. 24","author":"Brenner","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.ajem.2024.03.005_bb0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1745-6215-11-40","article-title":"The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial","volume":"11","author":"Shakur","year":"2010","journal-title":"Trials"},{"issue":"10135","key":"10.1016\/j.ajem.2024.03.005_bb0045","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","article-title":"Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial","volume":"391","author":"Sprigg","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ajem.2024.03.005_bb0050","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00068-018-0974-z","article-title":"Benefits of the tranexamic acid in head trauma with no extracranial bleeding: a prospective follow-up of 180 patients","volume":"45","author":"Chakroun-Walha","year":"2019","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"10210","key":"10.1016\/j.ajem.2024.03.005_bb0055","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","article-title":"Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): A randomised, placebo-controlled trial","volume":"394","author":"Roberts","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ajem.2024.03.005_bb0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/atr.atr_43_22","article-title":"The impact of tranexamic acid on brain contusion and intraparenchymal hemorrhage in patients with head injury","volume":"11","author":"Fakharian","year":"2022","journal-title":"Arch Trauma Res"},{"issue":"1","key":"10.1016\/j.ajem.2024.03.005_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cjtee.2016.02.005","article-title":"The effect of tranexamic acid in traumatic brain injury: a randomized controlled trial","volume":"20","author":"Jokar","year":"2017","journal-title":"Chin J Traumatol"},{"issue":"10","key":"10.1016\/j.ajem.2024.03.005_bb0070","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajem.2024.03.005_bb0075","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.934475","article-title":"Editorial: review articles, systematic reviews, meta-analysis, and the updated preferred reporting items for systematic reviews and meta-analyses (PRISMA) 2020 guidelines","volume":"27","author":"Parums","year":"2021","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ajem.2024.03.005_bb0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-227X-13-20","article-title":"Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial","volume":"13","author":"Yutthakasemsunt","year":"2013","journal-title":"BMC Emerg Med"},{"issue":"2","key":"10.1016\/j.ajem.2024.03.005_bb0085","first-page":"223","article-title":"Effect of intravenous tranexamic acid on intracerebral brain hemorrhage in traumatic brain injury","volume":"31","author":"Safari","year":"2021","journal-title":"Turk Neurosurg"},{"issue":"10","key":"10.1016\/j.ajem.2024.03.005_bb0090","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.2020.8958","article-title":"Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury","volume":"324","author":"Rowell","year":"2020","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.ajem.2024.03.005_bb0095","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/1574887114666191118111826","article-title":"Intravenous tranexamic acid for brain contusion with Intraparenchymal hemorrhage: randomized, double-blind, placebo-controlled trial","volume":"15","author":"Mousavinejad","year":"2020","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.ajem.2024.03.005_bb0100","first-page":"107","article-title":"The effect of intravenous tranexamic acid on preventing the progress of cerebral hemorrhage in patients with brain traumatic injuries compared to placebo: a randomized clinical trial","volume":"34","author":"Mojallal","year":"2020","journal-title":"Med J Islam Repub Iran"},{"key":"10.1016\/j.ajem.2024.03.005_bb0105","doi-asserted-by":"crossref","first-page":"e748","DOI":"10.1016\/j.wneu.2017.10.075","article-title":"Effect of tranexamic acid on prevention of hemorrhagic mass growth in patients with traumatic brain injury","volume":"109","author":"Fakharian","year":"2018","journal-title":"World Neurosurg"},{"issue":"4","key":"10.1016\/j.ajem.2024.03.005_bb0110","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2174\/1574887114666190620112829","article-title":"Intravenous tranexamic acid for subdural and epidural intracranial hemorrhage: randomized, double-blind, placebo-controlled trial","volume":"14","author":"Ebrahimi","year":"2019","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.ajem.2024.03.005_bb0115","article-title":"Effect of tranexamic acid in traumatic brain injury: A nested randomised, placebo controlled trial (CRASH-2 intracranial bleeding study)","volume":"343","year":"2011","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.ajem.2024.03.005_bb0120","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1089\/neu.2015.4039","article-title":"Time course of coagulation and fibrinolytic parameters in patients with traumatic brain injury","volume":"33","author":"Nakae","year":"2016","journal-title":"J Neurotrauma"},{"issue":"1","key":"10.1016\/j.ajem.2024.03.005_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-021-00264-3","article-title":"Trauma-induced coagulopathy","volume":"7","author":"Moore","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"22","key":"10.1016\/j.ajem.2024.03.005_bb0130","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1182\/blood.V128.22.206.206","article-title":"Reperfusion shutdown: delayed onset of fibrinolysis resistance after resuscitation from hemorrhagic shock is associated with increased circulating levels of plasminogen activator inhibitor-1 and postinjury complications","volume":"128","author":"Moore","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ajem.2024.03.005_bb0135","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1213\/ANE.0000000000004234","article-title":"Fibrinolysis shutdown in trauma: historical review and clinical implications","volume":"129","author":"Moore","year":"2019","journal-title":"Anesth Analg"},{"issue":"9771","key":"10.1016\/j.ajem.2024.03.005_bb0140","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(11)60278-X","article-title":"The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial","volume":"377","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ajem.2024.03.005_bb0145","series-title":"Rationale for the Selective Administration of Tranexamic Acid to Inhibit Fibrinolysis in the Severely Injured Patient","first-page":"S110","volume":"56","author":"Moore","year":"2016"},{"key":"10.1016\/j.ajem.2024.03.005_bb0150","series-title":"Tranexamic Acid is Associated with Increased Mortality in Patients with Physiological Fibrinolysis","first-page":"438","volume":"220","author":"Moore","year":"2017"},{"issue":"3","key":"10.1016\/j.ajem.2024.03.005_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282726","article-title":"Efficacy and safety of tranexamic acid in intracranial haemorrhage: a meta-analysis","volume":"18","author":"Xiong","year":"2023","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.ajem.2024.03.005_bb0160","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40263-019-00608-4","article-title":"Tranexamic acid in cerebral hemorrhage: a meta-analysis and systematic review","volume":"33","author":"Hu","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ajem.2024.03.005_bb0165","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ajem.2021.09.051","article-title":"Efficacy and safety of tranexamic acid in aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials","volume":"50","author":"Liu","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2024.03.005_bb0170","doi-asserted-by":"crossref","first-page":"1203285","DOI":"10.1155\/2016\/1203285","article-title":"Intracerebral hemorrhage, oxidative stress, and antioxidant therapy","volume":"2016","author":"Duan","year":"2016","journal-title":"Oxid Med Cell Long"},{"issue":"1","key":"10.1016\/j.ajem.2024.03.005_bb0175","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/02688697.2014.950632","article-title":"Acute traumatic coagulopathy in the setting of isolated traumatic brain injury: definition, incidence and outcomes","volume":"29","author":"Epstein","year":"2015","journal-title":"Br J Neurosurg"},{"issue":"4","key":"10.1016\/j.ajem.2024.03.005_bb0180","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00068-018-0974-z","article-title":"Benefits of the tranexamic acid in head trauma with no extracranial bleeding: a prospective follow-up of 180 patients","volume":"45","author":"Chakroun-Walha","year":"2019","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"6","key":"10.1016\/j.ajem.2024.03.005_bb0185","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1097\/TA.0000000000001445","article-title":"Early tranexamic acid administration ameliorates the endotheliopathy of trauma and shock in an in vitro model","volume":"82","author":"Diebel","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"issue":"12","key":"10.1016\/j.ajem.2024.03.005_bb0190","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1111\/jth.14603","article-title":"Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis","volume":"17","author":"Draxler","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.ajem.2024.03.005_bb0195","doi-asserted-by":"crossref","DOI":"10.1186\/s40560-020-00460-5","article-title":"Efficacy and safety of tranexamic acid administration in traumatic brain injury patients: a systematic review and meta-analysis","volume":"8","author":"Yokobori","year":"2020","journal-title":"J Intensive Care"},{"issue":"1","key":"10.1016\/j.ajem.2024.03.005_bb0200","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00134-020-06279-w","article-title":"Efficacy and safety of tranexamic acid in acute traumatic brain injury: a systematic review and meta-analysis of randomized-controlled trials","volume":"47","author":"Lawati","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ajem.2024.03.005_bb0205","first-page":"156","article-title":"Ultra-early tranexamic acid after subarachnoid hemorrhage: A randomized controlled trial","volume":"12","author":"Lo","year":"2021","journal-title":"Lancet 2021 Surg Neurol Int"},{"issue":"9734","key":"10.1016\/j.ajem.2024.03.005_bb0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ajem.2024.03.005_bb0215","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2165\/00003495-199957060-00017","article-title":"Tranexamic acid: a review of its use in surgery and other indications","volume":"57","author":"Dunn","year":"1999","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.ajem.2024.03.005_bb0220","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1111\/j.1538-7836.2007.02717.x","article-title":"Evaluation of aprotinin and tranexamic acid in different in vitro and in vivo models of fibrinolysis, coagulation and thrombus formation","volume":"5","author":"Sperzel","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ajem.2024.03.005_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.injury.2023.111008","article-title":"Does tranexamic acid increase venous thromboembolism risk among trauma patients? A prospective multicenter analysis across 17 level I trauma centers","author":"Knowlton","year":"2023","journal-title":"Injury"},{"issue":"1","key":"10.1016\/j.ajem.2024.03.005_bb0230","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.24558","article-title":"Tranexamic acid-associated seizures: causes and treatment","volume":"79","author":"Lecker","year":"2016","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ajem.2024.03.005_bb0235","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1528-1157.1982.tb05051.x","article-title":"Feline generalized epilepsy induced by tranexamic acid (AMCA)","volume":"23","author":"Pellegrini","year":"1982","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.ajem.2024.03.005_bb0240","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1124\/jpet.301.1.168","article-title":"Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid(a) receptor antagonistic effect","volume":"301","author":"Furtmuller","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.ajem.2024.03.005_bb0245","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s13054-021-03799-9","article-title":"Effect of tranexamic acid on thrombotic events and seizures in bleeding patients: A systematic review and meta-analysis","volume":"vol. 25","author":"Murao","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.ajem.2024.03.005_bb0250","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.seizure.2016.02.011","article-title":"Tranexamic acid-associated seizures: a meta-analysis","volume":"36","author":"Lin","year":"2016","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.ajem.2024.03.005_bb0255","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/2396987320901391","article-title":"Incidence and predictors of early seizures in intracerebral haemorrhage and the effect of tranexamic acid","volume":"5","author":"Law","year":"2020","journal-title":"Eur Stroke J"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675724001177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675724001177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T05:56:16Z","timestamp":1731563776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675724001177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":51,"alternative-id":["S0735675724001177"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2024.03.005","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of tranexamic acid in acute traumatic brain injury: A meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2024.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}